---
title: "UOB Kay Hian Sticks to Its Buy Rating for Jacobson Pharma Corporation Limited (2633)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/283744778.md"
description: "UOB Kay Hian analyst maintained a Buy rating on Jacobson Pharma Corporation Limited yesterday and set a price target of HK$2.45.Claim 30% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks Jacobson Pharma Corporation Limited has an analyst consensus of Moderate Buy, with a price target consensus of HK$2.45."
datetime: "2026-04-23T01:05:55.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/283744778.md)
  - [en](https://longbridge.com/en/news/283744778.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/283744778.md)
---

# UOB Kay Hian Sticks to Its Buy Rating for Jacobson Pharma Corporation Limited (2633)

UOB Kay Hian analyst maintained a Buy rating on Jacobson Pharma Corporation Limited yesterday and set a price target of HK$2.45.

### Claim 30% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Jacobson Pharma Corporation Limited has an analyst consensus of Moderate Buy, with a price target consensus of HK$2.45.

### Related Stocks

- [02633.HK](https://longbridge.com/en/quote/02633.HK.md)
- [U10.SG](https://longbridge.com/en/quote/U10.SG.md)

## Related News & Research

- [11:05 ETThe Church of Jesus Christ of Latter-day Saints Commits $25 Million to the UNICEF-led Child Nutrition Fund](https://longbridge.com/en/news/287088476.md)
- [Tencent Music completes $2.6 billion acquisition of podcast platform Ximalaya](https://longbridge.com/en/news/286841981.md)
- [Dunkin' To Give Away 1 Mln Free Coffees For A Day](https://longbridge.com/en/news/286964019.md)
- [Palm Launches The Onboard Suite: Real-Time Access to 125 Million Businesses Across 150,000 Jurisdictions](https://longbridge.com/en/news/287063783.md)
- [BioInvent to Host Virtual KOL Event to Discuss BI-1808 for the Treatment of Ovarian Cancer, on May 27, 2026](https://longbridge.com/en/news/287043048.md)